Groen J, Koraka P, Velzing J, Copra C, Osterhaus A D
Laboratory for Exotic Viral Infections, WHO Center for Arboviruses and Hemorrhagic Fevers Reference and Research, Institute of Virology, Erasmus Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
Clin Diagn Lab Immunol. 2000 Nov;7(6):867-71. doi: 10.1128/CDLI.7.6.867-871.2000.
The performance of six commercially available immunoassay systems for the detection of dengue virus-specific immunoglobulin M (IgM) and IgG antibodies in serum was evaluated. These included two IgM and IgG enzyme immunoassays (EIA) from MRL Laboratories and PanBio, a rapid immunochromatographic test (RIT) from PanBio, immunofluorescence assays (IFA) from Progen, a dot blot assay from Genelabs, and a dipstick EIA from Integrated Diagnostics (INDX). For this study a panel of 132 serum samples, including 90 serum samples from patients with suspected dengue virus infection and 42 serum samples from patients with other viral infections, was used. In addition, serial serum samples from two monkeys experimentally immunized and challenged with dengue virus type 2 were used. Results were considered conclusive when concordant results were obtained with four of the six antibody-specific assays. Based on this definition, the calculated overall agreement for the human serum samples for the respective IgM immunoassays was 97% (128 of 132), with 34% (45 of 132) positive serum samples, 63% (83 of 132) negative samples, and 3% of samples (4 of 132) showing discordant results. The calculated overall agreement for the IgG assays was 94% (124 of 132), with 49% (65 of 132) positive, 45% (59 of 132) negative, and 6% (8 of 132) discordant results, respectively. The sensitivities of the dengue virus-specific assays evaluated varied between 71 and 100% for IgM and between 52 and 100% for IgG, with specificities of 86 to 96% and 81 to 100%, respectively. The relative sensitivities of the respective IgM assays measured with the monkey serum samples were comparable with those obtained with 12 serial serum samples from humans. Overall performance, based on the sum of the agreement, sensitivity, specificity, and Kappa statistics of the IgM and IgG immunoassays, showed that the antibody detection systems from INDX and Genelabs and the MRL and PanBio EIA are useful and reliable assays for dengue virus serodiagnosis.
评估了六种市售免疫测定系统检测血清中登革病毒特异性免疫球蛋白M(IgM)和IgG抗体的性能。这些系统包括来自MRL实验室和PanBio的两种IgM和IgG酶免疫测定(EIA)、来自PanBio的快速免疫层析试验(RIT)、来自Progen的免疫荧光测定(IFA)、来自Genelabs的斑点印迹测定以及来自Integrated Diagnostics(INDX)的试纸条EIA。本研究使用了一组132份血清样本,其中包括90份疑似登革病毒感染患者的血清样本和42份其他病毒感染患者的血清样本。此外,还使用了两只经登革病毒2型实验免疫和攻击的猴子的系列血清样本。当六种抗体特异性测定中有四种获得一致结果时,结果被认为是确定的。基于这一定义,计算得出人血清样本中各IgM免疫测定的总体一致性为97%(132份中的128份),其中阳性血清样本占34%(132份中的45份),阴性样本占63%(132份中的83份),3%的样本(132份中的4份)结果不一致。IgG测定的计算总体一致性为94%(132份中的124份),阳性率为49%(132份中的65份),阴性率为45%(132份中的59份),不一致结果为6%(132份中的8份)。所评估的登革病毒特异性测定的敏感性,IgM在71%至100%之间,IgG在52%至100%之间,特异性分别为86%至96%和81%至100%。用猴子血清样本测量的各IgM测定的相对敏感性与用12份人类系列血清样本获得的结果相当。基于IgM和IgG免疫测定的一致性、敏感性、特异性和Kappa统计量的总和,总体性能表明INDX和Genelabs的抗体检测系统以及MRL和PanBio的EIA是用于登革病毒血清学诊断的有用且可靠的测定方法。